- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Elevated TyG index tied to increased risk of eGFR decline in patients with hypertension
Taiwan: An elevated triglyceride glucose (TyG) index is independently associated with an increased risk of estimated glomerular filtration rate (eGFR) in patients with hypertension, states a study published in The Journal of Clinical Hypertension.
The results indicate that the TyG index could serve as a useful predictor for a decline in renal function among hypertensive patients. Also, the association between the TyG index and renal events suggest that insulin resistance (IR) may be a critical factor in developing hypertensive nephropathy.
Hypertension is a major global health problem affecting about 1.4 billion people worldwide. One of the common complications linked with hypertension is a renal injury that could lead to CKD (chronic kidney disease) and RSRD (end-stage renal disease). Strict BP control has been shown to reduce the risk of renal damage, but it remains uncertain which hypertensive patients are particularly susceptible to this condition, Therefore, identifying novel biomarkers that can predict the development and progression of hypertension-induced renal injury is important.
Insulin resistance has been implicated in kidney damage and progression of nephropathy. Hence IR evaluation may be a valuable tool for assessing the evolution of hypertension-induced renal damage. In this context, the TyG index has emerged as a cost-effective and non-invasive alternative indicator to assess IR. Recent studies have shown that an elevated TyG index is tied to an increased risk of cardiovascular disease, diabetic nephropathy, and arterial stiffness progression. However, there is limited evidence supporting the association between the TyG index and hypertension-induced renal injury.
Thus, there is a need for further need to determine whether the TyG index can serve as a reliable biomarker to evaluate the severity and progression of hypertensive nephropathy. Therefore, Chin-Chou Huang, College of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan, and colleagues aimed to investigate whether the TyG index was correlated with renal function decline in hypertensive patients.
The study included Han Chinese participants with essential hypertension. The TyG index was calculated as ln[fasting triglycerides (mg/dL) * fasting glucose (mg/dL)/2]. The decline in renal function was defined as >25% decline in eGFR. The independent effect of the TyG index on renal events was investigated using the Cox proportional hazard regression model. 548 Han Chinese hypertensive participants with a mean age of 62.1 ± 14.3 years were eligible for enrollment.
The study revealed the following findings:
- During a mean follow-up period of 4.7 ± 3.1 years, 97 patients suffered from >25% decline in eGFR.
- Patients with eGFR decline had higher fasting triglyceride levels, fasting glucose levels, and TyG indexes when compared to those without eGFR decline.
- The Cox proportional hazard regression model revealed that the TyG index (hazard ratio [HR] = 1.490), office systolic blood pressure (HR = 1.013), diabetes mellitus (HR = 1.797), and baseline eGFR (HR = 1.015) were associated with renal events.
The study revealed a significant association between an elevated TyG index and an increased risk of eGFR decline of more than 25%.
"The findings suggest that the TyG index could be a useful tool for evaluating future renal events," the researchers wrote. "While there is a need to further investigate the underlying mechanisms linking the TyG index to renal events, our findings support the clinical significance of this index for risk assessment in hypertension patients."
"Future studies should explore the potential use of the TyG index in clinical practice to improve early detection-making and prevention of renal damage," they concluded.
Reference:
Chen, C., Tsai, H., & Huang, C. Triglyceride glucose index and renal function decline in Han Chinese hypertensive patients. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14720
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751